These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 136768)

  • 1. No effect of factor Xa or tissue thromboplastin and factor VII on the activation of plasminogen.
    Wiman B; Holm T; Prydz H
    Thromb Res; 1976 Nov; 9(5):523-5. PubMed ID: 136768
    [No Abstract]   [Full Text] [Related]  

  • 2. The activation of factor X and factor X beta with factor VII or protein M.
    Seegers WH; Ghosh A
    Thromb Res; 1980 Feb 1-15; 17(3-4):501-6. PubMed ID: 6989015
    [No Abstract]   [Full Text] [Related]  

  • 3. Activation of 125I-factor IX and 125I-factor X: effect of tissue factor and factor VII, factor Xa and thrombin.
    Osterud B; Rapaport SI
    Scand J Haematol; 1980 Mar; 24(3):213-26. PubMed ID: 7375819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of lipoproteins on the tissue factor-dependent activation of factor X.
    Trimarchi A; Minestrini D; Palazzesi G; Cassetti M
    Int J Clin Lab Res; 1992; 22(2):115-8. PubMed ID: 1504304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A modified two-stage assay method for tissue-thromboplastin (TPLN).
    Kale NR
    Thromb Diath Haemorrh; 1966 May; 15(3):403-12. PubMed ID: 4965683
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma high density lipoproteins inhibit the activation of coagulation factor X by factor VIIa and tissue factor.
    Carson SD
    FEBS Lett; 1981 Sep; 132(1):37-40. PubMed ID: 6795061
    [No Abstract]   [Full Text] [Related]  

  • 7. Activation of bovine factor IX by the reaction product of bovine factor VII and human tissue factor.
    Liu DY; Rosen S
    Chin Med J (Engl); 1994 Mar; 107(3):181-5. PubMed ID: 8088177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A sensitive assay of extrinsic coagulation pathway inhibitor (EPI) in plasma and plasma fractions.
    Sandset PM; Abildgaard U; Pettersen M
    Thromb Res; 1987 Aug; 47(4):389-400. PubMed ID: 3499007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue factor is the only activator of coagulation in cultured human lung cancer cells.
    Keller T; Salge U; König H; Dodt J; Heiden M; Seitz R
    Lung Cancer; 2001; 31(2-3):171-9. PubMed ID: 11165396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic peptide analogs of tissue factor and factor VII which inhibit factor Xa formation by the tissue factor/factor VIIa complex.
    Rønning HF; Risøen UC; Orning L; Sletten K; Sakariassen KS
    Thromb Res; 1996 Oct; 84(2):73-81. PubMed ID: 8897697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The factor VIII-independent activation of factor X by factors IXa and VII in plasma.
    Ofosu F; Blajchman MA; Modi G; Hirsh J
    Thromb Res; 1981 Jan 1-15; 21(1-2):23-33. PubMed ID: 6785896
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of oestrogen dose and progestogen type on haemostatic changes in women taking low dose oral contraceptives.
    Norris LA; Bonnar J
    Br J Obstet Gynaecol; 1996 Mar; 103(3):261-7. PubMed ID: 8630312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Massive trauma. Effect of intravascular coagulation on prognosis.
    String T; Robinson AJ; Blaisdell FW
    Arch Surg; 1971 Apr; 102(4):406-11. PubMed ID: 4251849
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical use of a method for the determination of factor VII by a chromogenic substrate.
    Margaritella P; Deutsch E
    Thromb Res; 1981 Mar; 21(6):585-91. PubMed ID: 7268701
    [No Abstract]   [Full Text] [Related]  

  • 15. Kinetics of human factor VII activation.
    Butenas S; Mann KG
    Biochemistry; 1996 Feb; 35(6):1904-10. PubMed ID: 8639673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary procoagulant behaves as tissue factor by promoting factor VIIa-catalyzed activation of factor X.
    Kurosawa S; Matsuda M; Aoki N
    Thromb Res; 1984 Mar; 33(6):595-606. PubMed ID: 6609450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experience with chromogenic substrates in studies of clotting and fibrinolytic systems.
    Chmielewska J; Latallo ZS
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):111-4. PubMed ID: 6177591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thrombogenicity of a new prothrombin complex concentrate].
    Klöcking HP; Klessen C; Jablonowski C; Meerbach W; Dornheim G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(5):645-61. PubMed ID: 6083940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and properties of an abnormal blood coagulation factor IX (factor IXBm)/kinetics of its inhibition of factor X activation by factor VII and bovine tissue factor.
    Osterud B; Kasper CK; Lavine KK; Prodanos C; Rapaport SI
    Thromb Haemost; 1981 Feb; 45(1):55-9. PubMed ID: 7245126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The action of high-dose factor VIIa (FVIIa) in a cell-based model of hemostasis.
    Hoffman M; Monroe DM
    Dis Mon; 2003 Jan; 49(1):14-21. PubMed ID: 12525825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.